Evidence map›Paper›PMID 38693570›Full record

ArticleBMC medicine2024

The effectiveness of a standardized tobacco cessation program on psychophysiological parameters in patients with addiction undergoing long-term rehabilitation: a quasi-experimental pilot study.

J Fuchshuber, H Schöber, M Wohlmuth, H Senra, C Rominger, A Schwerdtfeger, H F Unterrainer

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06803706 (Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06803706 narecruitingnot on this mapstarted 2025, after this paper: background citation

Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy: A Randomized Controlled Trial

TypeinterventionalSponsorSigmund Freud PrivatUniversitatRan2025 to 2026Enrolled150ConditionsSubstance Use Disorder (SUD), Alcohol Use Disorder (AUD), Nicotine Addiction, Healthy Adult ParticipantsArms6-weeks CBT smoking cessation programme, Long-term drug therapy within a therapeutic community
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J FuchshuberDepartment of Psychoanalysis and Psychotherapy, Medical University Vienna, Vienna, Austria.
H SchöberInstitute of Psychology, University of Graz, Graz, Austria.
M WohlmuthInstitute of Psychology, University of Graz, Graz, Austria.
H SenraIEETA, University of Aveiro, Aveiro, Portugal.
C RomingerInstitute of Psychology, University of Graz, Graz, Austria.
A SchwerdtfegerInstitute of Psychology, University of Graz, Graz, Austria.
H F UnterrainerCenter for Integrative Addiction Research (CIAR), Grüner Kreis Society, Vienna, Austria. human.unterrainer@univie.ac.at.ORCID 0000-0002-4815-0214

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough there is a very high comorbidity between tobacco dependence and other addictive disorders, there are only few studies examining the implementation and outcomes of a tobacco cessation program in patients with addictive diseases. Therefore, the aim of this study is to investigate to what extent a standardized tobacco cessation program leads to improvements regarding psychological/physical parameters in patients with addiction undergoing therapy and whether there is a reduction in tobacco consumption.

methodsThe study took place in a therapeutic community specialized in addiction therapy. A total sample of 56 participants were non-randomly assigned to an intervention group (IG; n = 31) and a treatment as usual group (TAUG; n = 25). The IG participated in a 6-week tobacco cessation program, while the TAUG received no additional treatment. Both groups were assessed for changes in primary outcomes (tobacco dependence, smoked cigarettes per day (CPD), and general substance-related craving) and secondary outcomes (heart rate variability (HRV): root mean square of successive differences, self-efficacy, and comorbid psychiatric symptoms) at two measurement time points (pre- and post-treatment/6 weeks).

resultsWe observed significant improvements in self-efficacy (F

conclusionsThe results highlight the potential benefit of an additional tobacco cessation program as part of a general addiction treatment. Although no improvements in the physiological domain were observed, there were significant improvements regarding self-efficacy and CPD in the IG compared to the TAUG. Randomized controlled trials on larger samples would be an important next step.

trial registrationISRCTN15684371.

Indexed as

Tobacco Use CessationAdultFemaleHumansMaleMiddle AgedPilot ProjectsTobacco Use DisorderTreatment OutcomeAddiction therapy outcomeHeart rate variabilitySelf-efficacyTobacco cessationTobacco dependence

Identifiers

PMID38693570
PMCPMC11064355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.